These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 32102656)

  • 21. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
    Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
    Wang LL; Zhang M
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis.
    Tuo Z; Liang L; Zhou R
    J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
    Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X
    Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development.
    Wu F; Mo Q; Wan X; Dan J; Hu H
    J Cell Biochem; 2019 Mar; 120(3):2836-2846. PubMed ID: 29095526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
    Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
    Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
    Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
    RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
    Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
    RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.
    Liang Z; Kong R; He Z; Lin LY; Qin SS; Chen CY; Xie ZQ; Yu F; Sun GQ; Li CG; Fu D; Jiang GX; Chen J; Ma YS
    Oncotarget; 2017 Jul; 8(29):47389-47399. PubMed ID: 28537888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.
    Zhuang ZL; Tian FM; Sun CL
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5132-5136. PubMed ID: 28051257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
    Xia LH; Yan QH; Sun QD; Gao YP
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.